Merck & Co.

Wire

Merck & Co. seeks to acquire Seagen in a reportedly $40 billion deal
ByNNR July 7, 2022July 7, 2022

NEW YORK: Merck & Co. seeks to acquire Seagen in a reportedly $40 billion deal or more, the Wall Street Journal reported Thursday. While talks could fall apart, the companies are discussing a price near $200 per share and want to come…

Read More Merck & Co. seeks to acquire Seagen in a reportedly $40 billion deal
Australian Exchange

Starpharma signs research agreement with MSD
ByNNR February 12, 2021February 12, 2021

MELBOURNE: Starpharma Holdings has signed a Research Agreement with MSD, the tradename of Merck & Co., Inc., Kenilworth NJ USA. Under the agreement, MSD will conduct a preclinical research evaluation of dendrimer based Antibody Drug Conjugates (ADCs) utilising Starpharma’s proprietary…

Read More Starpharma signs research agreement with MSD